Bipartisan FDA reform bill could pass in 1996, Kennedy staffer says.
This article was originally published in The Tan Sheet
Executive Summary
KENNEDY's "FOUR PILLARS" OF FDA REFORM INCLUDE IMPROVED MANAGEMENT and IND/NDA review process changes, a staffer to Sen. Edward Kennedy (D-Mass.) told a Progress & Freedom Foundation conference on FDA reform Feb. 7 in Washington, D.C. David Nexon, health office staff director for the Senate Labor and Human Resources Committee's ranking Democrat, defined "better management" as "improved consistency, improved fairness in dealing with companies and improved predictability."